GLP-1 Market
LLY $1270.75 ▼ -1.0% NVO $39.27 ▼ -0.2% PFE $29.72 ▼ -1.3% VKTX $26.64 ▼ -0.3% KLRA $13.16 ▲ +2.1% GPCR $22.41 ▼ -2.1% RHHBY $59.12 ▲ +3.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Locally available low-dose semaglutide

Company
Asian Institute Of Medical Sciences
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 21, 2026

Find a Clinical Trial Near Me

See recruiting studies for Locally available low-dose semaglutide and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07513168

    Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults

    Not yet reported Asian Institute Of Medical Sciences 60 participants Est. completion 2026-12-01 1 site Added to GLP-1
    Other conditions: Obesity, Weight Reduction, Cardiometabolic Risk Factors
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Locally available low-dose semaglutide, Locally available low-dose semaglutide (0.25 mg, 0.5 mg, 1 mg)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.